HCW Biologics
Price & Volume
Stats
See more52W Range | $1.51-$25.43 |
Market Cap | $5.3M |
Shares Short | 11,245 |
Financials
See moreRevenue (12 Mos) | $832,841 |
Revenue Growth (YoY) | -98.9% |
Gross Profit (12 Mos) | $166,568 |
Diluted EPS | -$16.41 |
News
See moreYahoo Finance • last month
HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease
Yahoo Finance • last month
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
Yahoo Finance • 2 months ago
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Yahoo Finance • 2 months ago
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment
About
CEO | Dr. Hing C. Wong Ph.D. |
Address | 2929 North Commerce Parkway, Miramar, FL, United States, 33025 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 36 |
